Compare Adaptive Biotechnologies Corp (ADPT) vs Dow Inc (DOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Dow Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Dow Inc trades at $31.24 (market cap $22.58B). The key difference: Dow Inc is far larger — about 5.6× Adaptive Biotechnologies Corp's market cap, and Dow Inc pays a 4.48% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | DOW | |
|---|---|---|
Market Cap | $4.04B | $22.58B |
Sector | Health | Basic Materials |
52-Week High | $25.45 | $41.87 |
52-Week Low | $12.30 | $20.65 |
Enterprise Value | $4.10B | $38.27B |
Dividend Yield | — | 4.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →
